Key result
PITA-CABG is associated with ~74% 10-year survival in multivessel coronary revascularization.
Cohort (n=924)
Answers are grounded in this paper and cite their sources.
The PITA-CABG technique for multi-vessel revascularization demonstrates excellent 10-year survival and low operative mortality, with wound complications minimized by a bespoke SSI bundle.
Objective This study aims to assess the long-term outcomes and survival of patients who underwent PITA-CABG in multi-vessel myocardial revascularisation with a bespoke surgical site infection (SSI) bundle. Methods PITA-CABG technique involves multi-vessel myocardial revascularization by connecting the right internal thoracic artery (RITA) end-to-side to in-situ left internal thoracic artery (LITA) in a Y-graft with sequential coronary anastamoses. Bilateral internal mammary arteries are harvested by extra-pleural skeletonised technique. A cohort of 924 patients from April 2012 to July 2024 who underwent isolated PITA-CABG was analysed. Survival analysis explored the relationship between Euroscore, left ventricular (LV) function, body mass index, pulmonary disease, extracardiac arteriopathy, and survival. Univariate analysis preceded Cox regression with stepwise variable selection for independent predictors, all at a 5% significance level. Results Mean age is 64 years, and 83.4% (771/924) were male. On average patients received 3.4 anastomoses/patient (2 grafts (105), 3 grafts (425), 4 grafts (334), 5 grafts (52), 6 grafts (8)). Mean cardiopulmonary bypass and mean aortic cross clamp times were 70.1 & 57.1mins, respectively. Rates of SSIs was 2.1% (20/924) total (1.6% (15/924) superficial wound infection, 0.5% (5/924) deep wound infection). 0.4% (4/924) required new onset haemofiltration due to acute renal failure, and 0.2% (2/924) developed a post- operative neurological deficit. The 30 day mortality rate was 0.04% (arrhythmia, n=1 , mesenteric ischaemia, n=1, multiorgan failure, n=1). Survival rates at one, five, and ten years were 98.8%, 93.3%, and 74.4%, respectively (Figure 1). Notably, LV function (Figure 2), pulmonary disease, and extracardiac arteriopathy were identified as independent predictors of survival (p<0.001 for all variables). Patients with poor LV function experienced a 2.9-fold higher mortality risk, while those with moderate LV function had a 2.1-fold higher risk. Additionally, the presence of pulmonary disease increased the risk of death by 1.7 times, and extracardiac arteriopathy was associated with a 2.2-fold higher risk. Conclusions The study reveals a low operative mortality rate for PITA-CABG with a excellent 10- year survival. Patients with compromised LV function, pulmonary diseases, or extracardiac arteriopathy were identified as having a notably increased mortality risk. Wound complications are minimised by employing a bespoke SSI bundle.
No takes yet. Share an insight, caveat, or question.
Yong et al. (2025) conducted a cohort in Multi-vessel myocardial revascularisation (n=924). PITA-CABG (pure internal thoracic artery coronary artery bypass grafting) was evaluated on 10-year survival. PITA-CABG for multi-vessel revascularization was associated with a low 30-day mortality rate and an excellent 10-year survival rate of 74.4%.
Synapse has enriched 10 related papers. Consider them for comparative context: